Disclosures for "Improvement in Patient-reported Disease Severity, Cognitive Functioning, and Fatigue in Patients With Narcolepsy Type One Treated With Alixorexton, an Orexin Two Receptor Agonist, in the Vibrance-1 Phase Two Study "
-
Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for idorsia. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for JAZZ. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avadel. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alkermes. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Centessa. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bioprojet. Yves Dauvilliers, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony Bioscience.
-
Prof. Grunstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly . Prof. Grunstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apnimed. The institution of Prof. Grunstein has received research support from Alkermes. The institution of Prof. Grunstein has received research support from Eli Lilly.
-
Dr. Mignot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Mignot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceutical. Dr. Mignot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharmaceuticals, Inc. . Dr. Mignot has received personal compensation in the range of $0-$499 for serving as a Consultant for EcoR1. Dr. Mignot has received personal compensation in the range of $0-$499 for serving as a Consultant for ApneaCo. Dr. Mignot has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai Pharmaceuticals. Dr. Mignot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Centessa .
-
The institution of Dr. Lammers has received research support from Takeda.
-
David Plante has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. David Plante has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Harmony Biosciences. David Plante has received personal compensation in the range of $0-$499 for serving as a Consultant for Aditum Bio. David Plante has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. David Plante has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. David Plante has received intellectual property interests from a discovery or technology relating to health care. David Plante has received publishing royalties from a publication relating to health care.
-
The institution of Dr. Buntinx has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for J&J. The institution of Dr. Buntinx has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli-Lilly. The institution of Dr. Buntinx has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for ANIMA Research. Dr. Buntinx has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for ANIMA Medical. Dr. Buntinx has stock in ANIMA Research bv. Dr. Buntinx has stock in ANIMA Medical bv. Dr. Buntinx has stock in Linde Buntinx bv. Dr. Buntinx has stock in Elise Buntinx bv. Dr. Buntinx has stock in ANIMA Clinical. Dr. Buntinx has stock in ANeuroTech bv. Dr. Buntinx has stock in Integra Invest. Dr. Buntinx has stock in Integra bv. Dr. Buntinx has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Del Río Villegas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TAKEDA. Dr. Del Río Villegas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALKERMES.
-
Ms. Chen has nothing to disclose.
-
Dr. Hopkinson has received personal compensation for serving as an employee of Alkermes, Inc. An immediate family member of Dr. Hopkinson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CoRA Consulting LLC. Dr. Hopkinson has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Alberio. Dr. Hopkinson has stock in Alkermes, Inc.
-
Dr. Rege has received personal compensation for serving as an employee of Alkermes. Dr. Rege has stock in Alkermes. Dr. Rege has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Himes has received personal compensation for serving as an employee of Alkermes. Dr. Himes has stock in Alkermes.
-
Dr. Doane has received personal compensation for serving as an employee of Alkermes, Inc.. Dr. Doane has stock in Alkermes, Inc..
-
The institution of Dr. Plazzi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TAKEDA. The institution of Dr. Plazzi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOPROJET. The institution of Dr. Plazzi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for JAZZ. The institution of Dr. Plazzi has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for OREXIA. The institution of Dr. Plazzi has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for OREXIA/CENTESSA.